Analyst Consensus ?
ConsensusHold42 ratings
Bullish1638.1%
Neutral2252.4%
Bearish49.5%
FN2 Earnings Intelligence
The Progressive Corporation (PGR) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Underweight | Underweight | Maintain | Oct 15, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Oct 15, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 7, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Oct 5, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Sep 16, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 27, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Aug 17, 2026 |
| Morgan Stanley | Equal Weight | Underweight | Upgrade | Jul 24, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Jul 16, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 16, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 16, 2026 |
| HSBC | Hold | Hold | Maintain | Jul 6, 2026 |
| Jefferies | Hold | Hold | Maintain | Mar 24, 2026 |
| Citigroup | Buy | Buy | Maintain | Feb 4, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Oct 28, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Oct 17, 2025 |
| Roth MKM | Buy | Buy | Maintain | Feb 25, 2025 |
| TD Cowen | Hold | Hold | Maintain | Nov 8, 2024 |
| Piper Sandler | Overweight | Overweight | Maintain | Aug 15, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | Aug 18, 2022 |
| MKM Partners | Buy | Buy | Maintain | Jul 18, 2022 |
| Edward Jones | Hold | Buy | Downgrade | Feb 9, 2022 |
| Wolfe Research | Underperform | Underperform | Maintain | Aug 17, 2021 |
| Deutsche Bank | Buy | Buy | Maintain | Feb 1, 2021 |
| B. Riley Securities | Neutral | Buy | Downgrade | Mar 11, 2020 |
| B. Riley FBR | Neutral | Buy | Downgrade | Mar 11, 2020 |
| B. Riley | Neutral | Buy | Downgrade | Mar 11, 2020 |
| Buckingham Research | Neutral | Neutral | Maintain | Dec 6, 2019 |
| Buckingham | Neutral | Neutral | Maintain | Dec 6, 2019 |
| Keefe Bruyette & Woods | Market Perform | Outperform | Downgrade | May 17, 2018 |
| Sandler O'Neill | Buy | Hold | Upgrade | Mar 21, 2017 |
| Bank of America | Buy | Neutral | Upgrade | Mar 20, 2017 |
| Bernstein | Market Perform | Outperform | Downgrade | Jan 19, 2016 |
| Sterne Agee CRT | Neutral | Neutral | Maintain | Sep 21, 2015 |
| JMP Securities | Outperform | Market Outperform | Maintain | Sep 16, 2015 |
| Janney Montgomery Scott | Buy | Neutral | Upgrade | Jan 7, 2015 |
| Janney Capital | Buy | Neutral | Upgrade | Jan 7, 2015 |
| Evercore Partners | Equal Weight | Underweight | Upgrade | Jul 15, 2014 |
| William Blair | Outperform | Underperform | Upgrade | Mar 21, 2014 |
| Nomura | Reduce | Reduce | Maintain | Dec 12, 2013 |
| RBC Capital | Sector Perform | Outperform | Downgrade | Mar 14, 2013 |
| Macquarie | Underperform | Neutral | Downgrade | Jan 17, 2013 |
Upside is calculated against the persisted current price $229.25. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $238 | $217.67 | +3.8% | Oct 19, 2026 |
| BMO Capital | Analyst unavailable | $216 | $218.46 | -5.8% | Oct 15, 2026 |
| Wells Fargo | Elyse Greenspan | $196 | $213.46 | -14.5% | Oct 15, 2026 |
| HSBC | Analyst unavailable | $216 | $212.05 | -5.8% | Oct 7, 2026 |
| Raymond James | Gregory Peters | $245 | $213.48 | +6.9% | Sep 21, 2026 |
| Mizuho Securities | Yaron Kinar | $230 | $221.31 | +0.3% | Sep 16, 2026 |
| UBS | Brian Meredith | $234 | $222.51 | +2.1% | Aug 27, 2026 |
| Roth Capital | Harry Fong | $245 | $217.27 | +6.9% | Aug 20, 2026 |
| Goldman Sachs | Alex Scott | $230 | $216.15 | +0.3% | Aug 19, 2026 |
| Jefferies | Andrew Andersen | $228 | $216.03 | -0.5% | Aug 19, 2026 |
| Cantor Fitzgerald | Ryan Tunis | $200 | $207.7 | -12.8% | Aug 17, 2026 |
| Mizuho Securities | Analyst unavailable | $236 | $210.75 | +2.9% | Aug 5, 2026 |
| Morgan Stanley | Bob Huang | $210 | $207.07 | -8.4% | Jul 24, 2026 |
| BMO Capital | Analyst unavailable | $205 | $205.22 | -10.6% | Jul 16, 2026 |
| Wells Fargo | Elyse Greenspan | $198 | $205.22 | -13.6% | Jul 16, 2026 |
| Evercore ISI | Analyst unavailable | $240 | $229.64 | +4.7% | Jul 10, 2026 |
| Mizuho Securities | Analyst unavailable | $243 | $232.9 | +6.0% | Jul 9, 2026 |
| HSBC | Vikram Gandhi | $221 | $232.22 | -3.6% | Jul 6, 2026 |
| UBS | Analyst unavailable | $230 | $220.17 | +0.3% | Jun 30, 2026 |
| Wells Fargo | Analyst unavailable | $205 | $224.34 | -10.6% | Jun 29, 2026 |
| Wells Fargo | Elyse Greenspan | $219 | $204.42 | -4.5% | Jun 18, 2026 |
| RBC Capital | Analyst unavailable | $208 | $197.89 | -9.3% | May 22, 2026 |
| BMO Capital | Michael Zaremski | $220 | $201.92 | -4.0% | May 20, 2026 |
| BMO Capital | Analyst unavailable | $221 | $201.23 | -3.6% | Apr 16, 2026 |
| Wells Fargo | Elyse Greenspan | $218 | $201.23 | -4.9% | Apr 16, 2026 |
| Barclays | Alex Scott | $247 | $202.79 | +7.7% | Mar 18, 2026 |
| BMO Capital | Michael Zaremski | $208 | $203.21 | -9.3% | Mar 11, 2026 |
| Piper Sandler | Paul Newsome | $259 | $212.8 | +13.0% | Mar 2, 2026 |
| Goldman Sachs | Alex Scott | $225 | $203.69 | -1.9% | Feb 23, 2026 |
| UBS | Brian Meredith | $218 | $203.62 | -4.9% | Feb 23, 2026 |
| Evercore ISI | Analyst unavailable | $230 | $203.52 | +0.3% | Feb 19, 2026 |
| Roth Capital | Analyst unavailable | $235 | $203.32 | +2.5% | Feb 19, 2026 |
| Wells Fargo | Analyst unavailable | $214 | $203.28 | -6.7% | Feb 19, 2026 |
| Jefferies | Analyst unavailable | $216 | $209.29 | -5.8% | Feb 11, 2026 |
| UBS | Analyst unavailable | $226 | $208 | -1.4% | Feb 2, 2026 |
| BMO Capital | Analyst unavailable | $232 | $208.88 | +1.2% | Jan 29, 2026 |
| HSBC | Analyst unavailable | $224 | $201.97 | -2.3% | Jan 16, 2026 |
| BMO Capital | Michael Zaremski | $239 | $205.5 | +4.3% | Jan 15, 2026 |
| Mizuho Securities | Yaron Kinar | $240 | $205.83 | +4.7% | Jan 14, 2026 |
| Wells Fargo | Analyst unavailable | $240 | $216.5 | +4.7% | Jan 13, 2026 |
| Barclays | Alex Scott | $265 | $209.1 | +15.6% | Jan 8, 2026 |
| Goldman Sachs | Analyst unavailable | $227 | $209.1 | -1.0% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $237 | $213.98 | +3.4% | Jan 7, 2026 |
| Wells Fargo | Elyse Greenspan | $242 | $224.86 | +5.6% | Dec 19, 2025 |
| BMO Capital | Analyst unavailable | $253 | $227.27 | +10.4% | Dec 18, 2025 |
| Mizuho Securities | Analyst unavailable | $242 | $236.18 | +5.6% | Dec 15, 2025 |
| BMO Capital | Analyst unavailable | $256 | $223.16 | +11.7% | Dec 9, 2025 |
| BMO Capital | Michael Zaremski | $260 | $226 | +13.4% | Nov 21, 2025 |
| Wells Fargo | Analyst unavailable | $247 | $222.93 | +7.7% | Nov 20, 2025 |
| HSBC | Vikram Gandhi | $259 | $225.14 | +13.0% | Nov 17, 2025 |
| Jefferies | Andrew Andersen | $232 | $223.15 | +1.2% | Nov 14, 2025 |
| Goldman Sachs | Alex Scott | $245 | $216.64 | +6.9% | Oct 27, 2025 |
| Barclays | Alex Scott | $257 | $225.61 | +12.1% | Oct 20, 2025 |
| Morgan Stanley | Bob Huang | $214 | $225.61 | -6.7% | Oct 20, 2025 |
| Raymond James | Analyst unavailable | $265 | $223.34 | +15.6% | Oct 17, 2025 |
| BMO Capital | Analyst unavailable | $247 | $226.5 | +7.7% | Oct 16, 2025 |
| Wells Fargo | Elyse Greenspan | $246 | $226.5 | +7.3% | Oct 16, 2025 |
| UBS | Analyst unavailable | $261 | $244.82 | +13.8% | Oct 8, 2025 |
| Barclays | Analyst unavailable | $271 | $243.89 | +18.2% | Oct 8, 2025 |
| Evercore ISI | Analyst unavailable | $273 | $247.51 | +19.1% | Oct 1, 2025 |
| BMO Capital | Analyst unavailable | $252 | $243.49 | +9.9% | Sep 18, 2025 |
| Wells Fargo | Analyst unavailable | $265 | $243.49 | +15.6% | Sep 18, 2025 |
| BMO Capital | Analyst unavailable | $250 | $243.61 | +9.1% | Sep 17, 2025 |
| Morgan Stanley | Analyst unavailable | $267 | $249.21 | +16.5% | Aug 22, 2025 |
| Morgan Stanley | Bob Huang | $265 | $246.51 | +15.6% | Aug 11, 2025 |
| Morgan Stanley | Bob Huang | $330 | $288.24 | +43.9% | May 19, 2025 |
| Wells Fargo | Elyse Greenspan | $328 | $283.66 | +43.1% | May 7, 2025 |
| Goldman Sachs | Alex Scott | $294 | $246.74 | +28.2% | Nov 6, 2024 |
| BMO Capital | Michael Zaremski | $273 | $241.48 | +19.1% | Nov 4, 2024 |
| Goldman Sachs | Alex Scott | $292 | $250.74 | +27.4% | Oct 21, 2024 |
| Morgan Stanley | Bob Huang | $310 | $251.34 | +35.2% | Oct 18, 2024 |
| CFRA | Catherine Seifert | $290 | $252.61 | +26.5% | Oct 16, 2024 |
| Wells Fargo | Elyse Greenspan | $297 | $251.6 | +29.6% | Oct 16, 2024 |
| Citigroup | Michael Ward | $257 | $255.36 | +12.1% | Oct 4, 2024 |
| Goldman Sachs | Alex Scott | $280 | $255.44 | +22.1% | Sep 17, 2024 |
| Morgan Stanley | Bob Huang | $300 | $255.46 | +30.9% | Sep 16, 2024 |
| Bank of America Securities | Joshua Shanker | $309 | $255.46 | +34.8% | Sep 15, 2024 |
| Morgan Stanley | Bob Huang | $260 | $255.46 | +13.4% | Sep 14, 2024 |
| Wells Fargo | Elyse Greenspan | $282 | $251.31 | +23.0% | Sep 10, 2024 |
| Barclays | Alex Scott | $267 | $253.91 | +16.5% | Sep 4, 2024 |
| Bank of America Securities | Joshua Shanker | $312 | $252.2 | +36.1% | Sep 3, 2024 |
| Piper Sandler | Paul Newsome | $252 | $234.34 | +9.9% | Aug 15, 2024 |
| Goldman Sachs | Alex Scott | $262 | $235.17 | +14.3% | Aug 15, 2024 |
| Evercore ISI | David Motemaden | $257 | $234.34 | +12.1% | Aug 14, 2024 |
| HSBC | Vikram Gandhi | $253 | $222.99 | +10.4% | Aug 12, 2024 |
| BMO Capital | Michael Zaremski | $237 | $214.05 | +3.4% | Aug 7, 2024 |
| Jefferies | Yaron Kinar | $257 | $210 | +12.1% | Jul 17, 2024 |
| Morgan Stanley | Bob Huang | $255 | $212.53 | +11.2% | Jun 10, 2024 |
| Wells Fargo | Elyse Greenspan | $243 | $209.22 | +6.0% | May 20, 2024 |
| BMO Capital | Michael Zaremski | $235 | $209.25 | +2.5% | May 16, 2024 |
| CFRA | Catherine Seifert | $235 | $206.59 | +2.5% | Apr 15, 2024 |
| BMO Capital | Michael Zaremski | $234 | $206.85 | +2.1% | Apr 15, 2024 |
| Jefferies | Yaron Kinar | $245 | $203.9 | +6.9% | Apr 12, 2024 |
| Piper Sandler | Paul Newsome | $240 | $202.26 | +4.7% | Apr 12, 2024 |
| Morgan Stanley | Bob Huang | $247 | $206.15 | +7.7% | Apr 11, 2024 |
| Evercore ISI | David Motemaden | $215 | $204.88 | -6.2% | Mar 15, 2024 |
| Morgan Stanley | Bob Huang | $227 | $196.01 | -1.0% | Mar 6, 2024 |
| Raymond James | Gregory Peters | $165 | $157.41 | -28.0% | Oct 16, 2023 |
| Citigroup | Analyst unavailable | $111 | $137.45 | -51.6% | Feb 1, 2023 |
| Barclays | Analyst unavailable | $109 | $126.58 | -52.5% | Dec 15, 2022 |
| Raymond James | Gregory Peters | $140 | $125.16 | -38.9% | Aug 29, 2022 |
| Morgan Stanley | Analyst unavailable | $130 | $127.48 | -43.3% | Aug 19, 2022 |
| Barclays | Analyst unavailable | $106 | $127.29 | -53.8% | Aug 18, 2022 |
| MKM Partners | Analyst unavailable | $135 | $113.16 | -41.1% | Jul 18, 2022 |
| Morgan Stanley | Analyst unavailable | $121 | $112.9 | -47.2% | Jul 18, 2022 |
| Credit Suisse | Andrew Kligerman | $124 | $106.95 | -45.9% | Apr 28, 2022 |
| Jefferies | Yaron Kinar | $90 | $108.72 | -60.7% | Jan 30, 2022 |
| Evercore ISI | David Motemaden | $118 | $109.75 | -48.5% | Jan 14, 2022 |
| MKM Partners | Harry Fong | $115 | $101.33 | -49.8% | Dec 16, 2021 |
| KBW | Meyer Shields | $92 | $101.33 | -59.9% | Dec 16, 2021 |
| Morgan Stanley | Michael Phillips CFA | $85 | $94.61 | -62.9% | Jun 7, 2021 |
| Piper Sandler | Nicole Miller Regan | $96 | $94.65 | -58.1% | Apr 12, 2021 |
Track every rating change on PGR the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.